U.S. dollar banknotes and medicines are seen in this illustration taken, June 27, 2024. REUTERS/Dado Ruvic/Illustration

Retension Pharmaceuticals and TRex Bio filed for United States initial public offerings on Friday morning, adding breadth to the autumn IPO window. The dual filings follow a wave of biotech acquisitions by large drugmakers. Biotech listings have proven resilient against broader market pressures.